Use of anti-VEGF antibody in combination with chemotherapy for treating breast cancer

Details for Australian Patent Application No. 2009316409 (hide)

Owner GENENTECH, INC.

Inventors Fyfe, Gwendolyn; Phan, See Chun; Zhou, Xian

Agent Griffith Hack

Pub. Number AU-A-2009316409

PCT Pub. Number WO2010/059969

Priority 61/179,307 18.05.09 US; 61/117,102 22.11.08 US; 61/178,009 13.05.09 US

Filing date 20 November 2009

Wipo publication date 27 May 2010

International Classifications

A61K 31/00 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/04 (2006.01) Antineoplastic agents

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/059969 Priority application(s): WO2010/059969

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009316410-Compositions for detecting human interferon-alpha subtypes and methods of use

2009316392-Method for determining the risk of preeclampsia using PIGF-2 and PIGF-3 markers